Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05174780 · ClinicalTrials.gov registry record · NA

Myopia Control With a Innovative Spectacle Lens

A NA study of Myopia, sponsored by Essilor International.

Completed
Registry status
NA
Development phase
159
Enrollment target
9
Study locations

NCT05174780 is a NA study of Myopia that has completed, run by Essilor International. The registered enrollment target is 159 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (40% lower). The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05174780, a NA study of Myopia, has completed, sponsored by Essilor International.

COMPLETED
Registry status
NA
Development phase
159 participants
Enrollment target
9
Study locations

Study Summary

The purpose of this study is to demonstrate that the test spectacle lens is safe and effective in slowing myopia progression in children.

Conditions Studied

Myopia

Interventions

  • DEVICE innovative myopia control spectacle lens
  • DEVICE Single vision spectacle lens

Study Locations (9)

New York

  • SUNY College of Optometry - New York
  • Sacco Eye Group - Vestal

California

  • Scripps Poway Optometry - San Diego

Florida

  • Sabal Eye Care - Longwood

Illinois

  • Illinois College of Optometry - Chicago

Kansas

  • Kannarr Eye Care - Pittsburg

Massachusetts

  • New England College of Optometry - Boston

Pennsylvania

  • UPMC Children's Hospital of Pittsburgh - Pittsburgh

Texas

  • Mann Eye Institute - Houston

Trial Details

FieldValue
Enrollment Target 159 participants
Start Date 2021-12-29
Est. Completion 2025-10-20
Phase NA

Sponsor

Essilor International

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05174780

The ClinicalTrials.gov registry entry for NCT05174780 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (40% lower). The listed sponsor is Essilor International, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which innovative myopia control spectacle lens is the first listed.

NCT05174780 reports 9 study locations spanning 8 distinct geographic areas - top geographies include New York, California, Florida.

Frequently Asked Questions

What is clinical trial NCT05174780 about?

NCT05174780 is a clinical study titled "Myopia Control With a Innovative Spectacle Lens". The purpose of this study is to demonstrate that the test spectacle lens is safe and effective in slowing myopia progression in children.

What is the current status of trial NCT05174780?

This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2021-12-29. Estimated completion is 2025-10-20.

What conditions does trial NCT05174780 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT05174780?

The interventions under investigation include: innovative myopia control spectacle lens (DEVICE), Single vision spectacle lens (DEVICE).

Who is sponsoring clinical trial NCT05174780?

This trial is sponsored by Essilor International, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05174780 being conducted?

This trial has 9 study locations across California, Florida, Illinois, Kansas, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.